Therefore, we evaluated the paired immunologic expression of CD8+ lymphocytes, CD4+ lymphocytes, Foxp3+ lymphocytes, and the Galectin-9/Tim-3 pathway in the tumour microenvironment between primary and recurrent NPC from 95 patients. This evidence concerns the gene HAVCR2 and neoplasm.